Jesse Shefferman - 10 Jan 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Reporting relationship: CEO and President, Director
Issuer ticker: TARA
Reported as of: 10 Jan 2022
Net transaction value: -$31,852
SEC form: 4
Accepted by SEC: 12 Jan 2022, 16:18:49 UTC
Prior SEC filing: 05 Jan 2022
Next SEC filing: 15 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Jesse Shefferman

Key filing fact

Jesse Shefferman filed Form 4 for Protara Therapeutics, Inc. (TARA) on 12 Jan 2022.

Key facts

This page summarizes Jesse Shefferman's Form 4 filing for Protara Therapeutics, Inc. (TARA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Jan 2022, 16:18.

Change

Previous filing in this sequence was filed on 05 Jan 2022.
Current net transaction value: -$31,852.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TARA transaction

Common Stock

Tax liability

Transaction value: $31,852
Shares: -5,080
Change %: -0.58%
Price: $6.27
Shares after: 872,425
Date: 10 Jan 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020.